UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000010429
Receipt number R000012125
Scientific Title An exploratory study to evaluate biomarkers as predictive and /or prognostic factors of benefit from randomized phase ll study of mFOLFOX6+bevacizumab or mFOLFOX6+cetuximab in liver only metastasis from KRAS wild type colorectal cancer
Date of disclosure of the study information 2013/04/05
Last modified on 2019/10/10 10:35:23

No. Disposal Last modified on Item of update
1 Insert 2013/04/05 15:27:40
2 Update 2013/05/07 10:04:37 Recruitment status
3 Update 2013/05/07 10:05:22 Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
4 Update 2013/10/07 20:15:19 TEL
Email
Organization
Organization
Division name
Division name
Email
5 Update 2014/04/07 12:39:04 Division name
Division name
Address
Address
6 Update 2014/10/14 11:38:46 Institutions
7 Update 2014/10/14 11:39:11 Other related information
8 Update 2015/04/21 18:12:39 Condition
Condition
Key secondary outcomes
Key secondary outcomes
9 Update 2015/04/21 18:20:08 Address
Address
Institutions
10 Update 2015/04/21 18:22:58 Other related information
11 Update 2015/10/01 18:58:59 Institutions
12 Update 2016/03/28 11:09:33 Institutions
13 Update 2016/03/28 11:11:56 Recruitment status
14 Update 2017/10/31 16:30:31 Last follow-up date
Date of closure to data entry
Date trial data considered complete
15 Update 2019/10/10 10:35:23 Date of IRB